home / stock / nvcr / nvcr news


NVCR News and Press, NovoCure Limited From 07/14/23

Stock Information

Company Name: NovoCure Limited
Stock Symbol: NVCR
Market: NASDAQ
Website: novocure.com

Menu

NVCR NVCR Quote NVCR Short NVCR News NVCR Articles NVCR Message Board
Get NVCR Alerts

News, Short Squeeze, Breakout and More Instantly...

NVCR - MOORE KUEHN ANNOUNCES ENCOURAGES NOVOCURE LIMITED INVESTORS TO CONTACT LAW FIRM

MOORE KUEHN ANNOUNCES ENCOURAGES NOVOCURE LIMITED INVESTORS TO CONTACT LAW FIRM PR Newswire NEW YORK , July 14, 2023 /PRNewswire/ -- Moore Kuehn, PLLC, a securities and shareholder law firm located on Wall Street, is investigating potential claims against: ...

NVCR - Here's Why Novocure Stock Dropped 42% in June

2023-07-06 13:17:16 ET Novocure (NASDAQ: NVCR) shares dropped after publishing the results of an important clinical trial. The headlines looked positive at first glance, but the study raised concerns that lung cancer treatment might not have a place in the market. As a result, the s...

NVCR - Novocure to Report Second Quarter 2023 Financial Results

Novocure (NASDAQ: NVCR) announced today that it will report financial results for the second quarter 2023 on Thursday, July 27, 2023, before the U.S. financial markets open. Novocure management will host a conference call and webcast to discuss the company’s financial results for the three...

NVCR - Navigating NovoCure's TTFields Therapy In NSCLC: Mixed Results And Rating Downgrade

2023-06-13 23:49:18 ET Summary NovoCure's Tumor Treating Fields (TTFields) technology is seeking FDA approval for use in non-small cell lung cancer (NSCLC), despite the company's recent stock decline. The Q1 2023 financial report shows decreased net revenues and increased expenses...

NVCR - This Beaten-Down Growth Stock Has 99% Upside, According to Wall Street

2023-06-12 05:39:00 ET These days, investors can find plenty of reasons to feel nervous about buying stocks. Surging inflation, soaring interest rates, and geopolitical tensions are all legitimate concerns for most businesses. In these challenging times, investors would do well to remem...

NVCR - NovoCure upgraded at Wedbush citing balanced risk-reward setup

2023-06-07 08:38:13 ET NovoCure Limited ( NASDAQ: NVCR ) eked out a ~3% gain in the pre-market Wednesday as Wedbush upgraded the medical device maker to Neutral from Underperform, citing a favorable risk-reward setup following a ~43% slump in the previous session. Reviewing ...

NVCR - S&P, Dow, Nasdaq futures continue cautious trading

2023-06-07 06:21:00 ET Stock index futures were slightly lower, with investors still reluctant to commit to a firm direction a week before CPI and the Fed. S&P futures ( SPX ) -0.1% , Dow futures ( INDU ) -0.2% and Nasdaq 100 futures ( NDX:IND ) -0.1% wer...

NVCR - Why did NovoCure stock crash today? TTFields data

2023-06-06 21:51:06 ET Shares of NovoCure Limited ( NASDAQ: NVCR ) reached a 52-week low on Tuesday after the medical device maker and its China-based partner Zai Lab ( ZLAB ) posted late-stage data for their cancer treatment device, Tumor Treating Fields (TTFields), in patients...

NVCR - NovoCure: Misunderstood Lung Cancer Data Creates Enormous Buy Opportunity

2023-06-06 17:49:38 ET Summary NovoCure Limited's primary endpoint of phase 3 LUNAR study, using TTFields plus standard therapies for 2nd line metastatic NSCLC patients, was met with statistical significance with p-value of p=0.035. There is a Premarket Approval submission of TTFi...

NVCR - These 2 Nasdaq Stocks Are Plunging. Here's Why

2023-06-06 14:48:00 ET Wall Street has been on the upswing lately, gaining confidence about the ability of the economy to withstand inflationary pressures and tighter monetary policy. Small-cap stocks soared on Tuesday at midday, which helped drive the Nasdaq Composite (NASDAQINDEX: ^...

Previous 10 Next 10